• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

AB Science SA

+ Add to Watchlist

A8D:GR

10.220 EUR 0.090 0.89%

As of 02:12:02 ET on 07/14/2014.

Snapshot for AB Science SA (A8D)

Open: 10.235 Day's Range: 10.220 - 10.244 Volume: 0
Previous Close: 10.130 52wk Range: 10.000 - 21.650 1-Yr Rtn: -41.18%

Stock Chart for A8D

No chart data available.
  • A8D:GR 10.244
  • 1D
  • 1M
  • 1Y
10.130
Interactive A8D Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for A8D

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) -0.7100
Est. PEG Ratio -
Market Cap (M EUR) 336.50
Shares Outstanding (M) 32.93
30 Day Average Volume 72
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for A8D

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for A8D

AB Science SA provides biopharmaceutical services. The Company develops therapies for cancers, inflammatory diseases, and central nervous system diseases in human and veterinary medicine.

Alain MoussyCEO/Co-FounderLaurent GuyChief Financial Officer
Albert AhnPresident:USATom ChapuisDirector:Commercial
More Company Profile & Key Executives for A8D

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil